AIG
83
3
DFS
62
3
DE
62
2
APH
59
6
KSS
23
2
HCA
57
6
TXT
53
4
KLAC
63
6
TEL
63
5
ETR
68
5
RSG
73
3
T
71
3
SCHW
67
6
SWK
48
3
HON
58
3
HAS
43
2
QRVO
9
5
BAC
65
6
FE
64
4
TROW
24
-8
AIG
83
3
DFS
62
3
DE
62
2
APH
59
6
KSS
23
2
HCA
57
6
TXT
53
4
KLAC
63
6
TEL
63
5
ETR
68
5
RSG
73
3
T
71
3
SCHW
67
6
SWK
48
3
HON
58
3
HAS
43
2
QRVO
9
5
BAC
65
6
FE
64
4
TROW
24
-8
Financhill
Back

Theriva Biologics Stock Price Chart

Economy going through a "period of transition" - Your portfolio doesn't have to

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

TOVX
Theriva Biologics

Last Price:
$1.19
Seasonality Move:
-9.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight buying pressure.

Theriva Biologics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.29 Sell
20-day SMA: 1.43 Sell
50-day SMA: 1.45 Sell
200-day SMA: 3.17 Sell
8-day EMA: 1.27 Sell
20-day EMA: 1.36 Sell
50-day EMA: 1.44 Sell
200-day EMA: 3.7 Sell

Theriva Biologics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 37.54 Sell
Chaikin Money Flow: 11516 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 1.57) Sell
Bollinger Bands (100): (1.24 - 1.66) Sell

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Theriva Biologics Stock

Is Theriva Biologics Stock a Buy?

  • Theriva Biologics share price is 1.15 while TOVX 8-day simple moving average is 1.29, which is a Sell signal.
  • The stock price of TOVX is 1.15 while Theriva Biologics 20-day SMA is 1.43, which makes it a Sell.
  • Theriva Biologics 50-day simple moving average is 1.45 while TOVX share price is 1.15, making it a Sell technically.
  • TOVX stock price is 1.15 and Theriva Biologics 200-day simple moving average is 3.17, creating a Sell signal.

TOVX Technical Analysis vs Fundamental Analysis

Sell
27
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Sell
    The current Theriva Biologics [TOVX] share price is $1.15. The Score for TOVX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.

Theriva Biologics Stock Info

Market Cap:
3.2M
Price in USD:
1.15
Share Volume:
38K

Theriva Biologics 52-Week Range

52-Week High:
17.11
52-Week Low:
1.03
Sell
27
Theriva Biologics (TOVX) is a Sell

Theriva Biologics Share Price Forecast

Is Theriva Biologics Stock a Buy?

  • Theriva Biologics share price is 1.15 while TOVX 8-day exponential moving average is 1.27, which is a Sell signal.
  • The stock price of TOVX is 1.15 while Theriva Biologics 20-day EMA is 1.36, which makes it a Sell.
  • Theriva Biologics 50-day exponential moving average is 1.44 while TOVX share price is 1.15, making it a Sell technically.
  • TOVX stock price is 1.15 and Theriva Biologics 200-day simple moving average is 3.70, creating a Sell signal.

Fundamental Analysis of Theriva Biologics

Is Theriva Biologics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Theriva Biologics

Should I short Theriva Biologics stock?

* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.